Nucleic acids &

molecular biology

The promise of the human genome project is beginning to be fulfilled. Rapid whole-genome sequencing is now a reality. At the same time, ever more powerful techniques have been developed which have enabled tiny amounts of DNA to be detected from a sample; and we have editing techniques which allow us to precisely target and modify specific genes.

These exciting development are underpinned by core platform technologies. At Mewburn Ellis, we have considerable experience of providing IP protection for core platforms in molecular biology, as well as their innovative applications in research, agriculture and medicine. Many of our experienced patent attorneys have laboratory experience in this area and are supported by talented new recruits with up-to-date practical expertise.

Our work encompasses a wide range of genetic engineering, synthetic biology and analytic techniques. We have recently assisted the University of California, Berkley in the UK in obtaining European patents for CRISPR-Cas9 technology. We also have a long history of working with next-generation sequencing companies, including those developing approaches to single molecule and deep sequencing. 

Bioinformatics is becoming critically important in handling and interpreting the vast amount of data that can be generated from molecular biology. We offer a cross-disciplinary group with both IP and scientific expertise in this area. We also have a close working relationship with the specialist group of bioinformatics Examiners at the EPO. We can advise on how to write and prosecute patents with the best chances of success, taking into account the often complex requirements both in Europe and worldwide.

Read more on our Bioinformatics spotlight page.

Find out more about protecting your innovations

Pink-Pentagons-HQ

Bioinformatics & Digital Health

Learn More
Pink-Pentagons-HQ

Gene Editing

Learn More
Pink-Pentagons-HQ

Sequencing & Bioanalytics

Learn More
Pink-Pentagons-HQ

Synthetic Biology

Learn More
Patent_Landscape_in_Bioinformatics_and_Digital_Health_Special_Report_2021-2-Compressed

Special Report

Patent Landscape in Bioinformatics and Digital Health: a data-driven analysis

The words "digital health", "data driven" and "AI" have been on everyone's lips and in many headlines in the healthcare and life sciences sectors over the last couple of years. We set out to collect data on the patent landscape in the fields of bioinformatics and digital health, to see whether the growth we and our clients see in the field is reflected in the data and whether insights can be gained that will assist in designing better, more informed IP strategies.

Download the report

Read our Blogs

Event - From Innovation to Impact: Resolving Pinch Points in Cell and Gene Therapies, 23 July

Event - From Innovation to Impact: Resolving Pinch Points in Cell and Gene Therapies, 23 July

by Adam Gregory

On Wednesday 23 July, we were delighted to host our panel discussion and networking event "From Innovation to Impact: Resolving Pinch Points in Cell and Gene Therapies", featuring an incredible ...

Leucid Bio: the next generation of CAR T-cell therapies

Leucid Bio: the next generation of CAR T-cell therapies

by Laura Carney

CAR T-cell therapies hold the promise of curing solid tumour cancers. Dr John Maher, Chief Scientific Officer of Leucid Bio, explains how his biotech is developing the technology. Forward: features ...

At the Cutting Edge of Bioinformatics with Camille Terfve

At the Cutting Edge of Bioinformatics with Camille Terfve

by Camille Terfve

Mewburn Ellis partner Camille explains how her love for maths, biotech and the law come together in her remarkable role. Forward: features are independent pieces written for Mewburn Ellis discussing ...

Longevity Deals and IP Strategy

Longevity Deals and IP Strategy

by Katherine Collins

The recent announcement that Roche-backed Chugai Pharmaceutical has partnered with Gero to tackle age-related disease is the latest in a series of collaborations signalling growing interest from ...

Learn More

We work at every stage of the IP lifecycle

Protect

Drafting, Filing & Prosecution
Portfolio Management
Searching & Watching
Renewals & EP Validations

Read More

DEFEND

Pre-action Advice
Oppositions & Appeals
Litigation
Alternative Dispute Resolution

Read More

EXPLOIT

Strategic Advice
Commercial Issues
Transactions
Corporate Support      

Read More
Forward Magazines Overlapping 8

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.